Literature DB >> 26239178

Nonlinear cerebral atrophy patterns across the Alzheimer's disease continuum: impact of APOE4 genotype.

J D Gispert1, L Rami2, G Sánchez-Benavides3, C Falcon1, A Tucholka4, S Rojas5, J L Molinuevo6.   

Abstract

The progression of Alzheimer's disease (AD) is characterized by complex trajectories of cerebral atrophy that are affected by interactions with age and apolipoprotein E allele ε4 (APOE4) status. In this article, we report the nonlinear volumetric changes in gray matter across the full biological spectrum of the disease, represented by the AD-cerebrospinal fluid (CSF) index. This index reflects the subject's level of pathology and position along the AD continuum. We also evaluated the associated impact of the APOE4 genotype. The atrophy pattern associated with the AD-CSF index was highly symmetrical and corresponded with the typical AD signature. Medial temporal structures showed different atrophy dynamics along the progression of the disease. The bilateral parahippocampal cortices and a parietotemporal region extending from the middle temporal to the supramarginal gyrus presented an initial increase in volume which later reverted. Similarly, a portion of the precuneus presented a rather linear inverse association with the AD-CSF index whereas some other clusters did not show significant atrophy until index values corresponded to positive CSF tau values. APOE4 carriers showed steeper hippocampal volume reductions with AD progression. Overall, the reported atrophy patterns are in close agreement with those mentioned in previous findings. However, the detected nonlinearities suggest that there may be different pathological processes taking place at specific moments during AD progression and reveal the impact of the APOE4 allele.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amyloid; Biomarkers; Brain; MRI; Neuroinflammation; Tau; VBM

Mesh:

Substances:

Year:  2015        PMID: 26239178     DOI: 10.1016/j.neurobiolaging.2015.06.027

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  24 in total

1.  Neuroimaging and Dementia.

Authors:  Başar Bilgiç
Journal:  Noro Psikiyatr Ars       Date:  2018-03-19       Impact factor: 1.339

2.  Regionally specific changes in the hippocampal circuitry accompany progression of cerebrospinal fluid biomarkers in preclinical Alzheimer's disease.

Authors:  Christine L Tardif; Gabriel A Devenyi; Robert S C Amaral; Sandra Pelleieux; Judes Poirier; Pedro Rosa-Neto; John Breitner; M Mallar Chakravarty
Journal:  Hum Brain Mapp       Date:  2017-11-21       Impact factor: 5.038

3.  Associations Between Sub-Threshold Amyloid-β Deposition, Cortical Volume, and Cognitive Function Modulated by APOE ɛ4 Carrier Status in Cognitively Normal Older Adults.

Authors:  Dong Woo Kang; Sheng-Min Wang; Yoo Hyun Um; Nak Young Kim; Chang Uk Lee; Hyun Kook Lim
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

4.  The fornix provides multiple biomarkers to characterize circuit disruption in a mouse model of Alzheimer's disease.

Authors:  Alexandra Badea; Lauren Kane; Robert J Anderson; Yi Qi; Mark Foster; Gary P Cofer; Neil Medvitz; Anne F Buckley; Andreas K Badea; William C Wetsel; Carol A Colton
Journal:  Neuroimage       Date:  2016-08-10       Impact factor: 6.556

5.  Multivariate MR biomarkers better predict cognitive dysfunction in mouse models of Alzheimer's disease.

Authors:  Alexandra Badea; Natalie A Delpratt; R J Anderson; Russell Dibb; Yi Qi; Hongjiang Wei; Chunlei Liu; William C Wetsel; Brian B Avants; Carol Colton
Journal:  Magn Reson Imaging       Date:  2019-03-30       Impact factor: 2.546

6.  Diffuse reduction of cerebral grey matter volumes in Erdheim-Chester disease.

Authors:  Eli L Diamond; Vaios Hatzoglou; Sneha Patel; Omar Abdel-Wahab; Raajit Rampal; David M Hyman; Andrei I Holodny; Ashish Raj
Journal:  Orphanet J Rare Dis       Date:  2016-08-02       Impact factor: 4.123

7.  The APOE ε4 genotype modulates CSF YKL-40 levels and their structural brain correlates in the continuum of Alzheimer's disease but not those of sTREM2.

Authors:  Juan Domingo Gispert; Gemma C Monté; Marc Suárez-Calvet; Carles Falcon; Alan Tucholka; Santiago Rojas; Lorena Rami; Raquel Sánchez-Valle; Albert Lladó; Gernot Kleinberger; Christian Haass; José Luis Molinuevo
Journal:  Alzheimers Dement (Amst)       Date:  2016-12-22

Review 8.  The Rationale Behind the New Alzheimer's Disease Conceptualization: Lessons Learned During the Last Decades.

Authors:  José Luis Molinuevo; Carolina Minguillon; Lorena Rami; Juan Domingo Gispert
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

9.  Structural Connectivity Alterations Along the Alzheimer's Disease Continuum: Reproducibility Across Two Independent Samples and Correlation with Cerebrospinal Fluid Amyloid-β and Tau.

Authors:  Alan Tucholka; Oriol Grau-Rivera; Carles Falcon; Lorena Rami; Raquel Sánchez-Valle; Albert Lladó; Juan Domingo Gispert; José Luis Molinuevo
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

10.  Distinct Cognitive and Brain Morphological Features in Healthy Subjects Unaware of Informant-Reported Cognitive Decline.

Authors:  Gonzalo Sánchez-Benavides; Oriol Grau-Rivera; Raffaele Cacciaglia; Marc Suárez-Calvet; Carles Falcon; Carolina Minguillon; Nina Gramunt; Aleix Sala-Vila; Juan Domingo Gispert; José Luis Molinuevo
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.